Paper26311557
The effect of maternal obesity on the expression and functionality of placental P-glycoprotein: Implications in the individualized transplacental digoxin treatment for fetal heart failure.
Wang C and 8 others. Placenta, 2015. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. The effect of maternal obesity on the expression and functionality of placental P-glycoprotein: Implications in the individualized transplacental digoxin treatment for fetal heart failure. Papers, record 26311557. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26311557
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of maternal obesity on the expression and functionality of placental P-glycoprotein: Implications in the individualized transplacental digoxin treatment for fetal heart failure.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| ATP Binding Cassette Transporter, Subfamily B, Member 1 | Major topic |
| Obesity | Major topic |
| Placenta | Major topic |
| Pregnancy Complications | Major topic |
| Adult | |
| Animals | |
| Cardiotonic Agents | |
| Case-Control Studies | |
| Digoxin | |
| Disease Models, Animal | |
| Female | |
| Fetal Diseases | |
| Heart Failure | |
| Humans | |
| Mice, Inbred C57BL | |
| Precision Medicine | |
| Pregnancy | |
| Random Allocation |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 32174309 | Corrigendum to "The effect of maternal obesity on the expression and functionality of placental P-glycoprotein: Implications in the individualized transplacental digoxin treatment for fetal heart failure" [Placenta 36 (2015) 1138-1147]. | https://conductscience.org/library/papers/32174309 |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41751871 | Special Issue "Molecular and Cellular Research in Pregnancy-Related Complications". | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751871 | PubMed |
| 41501546 | Review: Systemic inflammation after stroke. Therapy and perspective. | Geroscience | 2026 | https://conductscience.org/library/papers/41501546 | PubMed |
| 41322281 | Changed expression of placental transporters and disrupted epigenetic patterns in a rat model of schizophrenia. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41322281 | PubMed |
| 40725223 | Alterations in P-glycoprotein Expression in the Placenta of Obese Rats and Humans. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725223 | PubMed |
| 38678254 | Obesity-induced blood-brain barrier dysfunction: phenotypes and mechanisms. | J Neuroinflammation | 2024 | https://conductscience.org/library/papers/38678254 | PubMed |
| 36997557 | ABCB1 expression is increased in human first trimester placenta from pregnant women classified as overweight or obese. | Sci Rep | 2023 | https://conductscience.org/library/papers/36997557 | PubMed |
| 35890272 | Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35890272 | PubMed |
| 34992073 | Regulation of Placental Efflux Transporters during Pregnancy Complications. | Drug Metab Dispos | 2022 | https://conductscience.org/library/papers/34992073 | PubMed |
| 34733804 | Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics? | Front Pediatr | 2021 | https://conductscience.org/library/papers/34733804 | PubMed |
| 32451908 | Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling. | Clin Pharmacokinet | 2020 | https://conductscience.org/library/papers/32451908 | PubMed |
| 31823387 | Placental transporter-mediated drug interactions and offspring congenital anomalies. | Br J Clin Pharmacol | 2020 | https://conductscience.org/library/papers/31823387 | PubMed |
| 27014074 | The Programming Power of the Placenta. | Front Physiol | 2016 | https://conductscience.org/library/papers/27014074 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26311557
GET https://conductscience.org/api/papers/v1/26311557/authors